Metraipolis › archive › dc_57c7c47bedea

SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42151900
DOI
10.1186/s12885-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-01T15:40:13.057Z
SHA-256 of the archived text
19ad3be6112fc1904f1d6cbec8ccbec403946185747fe4579b1e26977d84a28e
Stable URL of this page
https://metraipolis.com/documento/dc_57c7c47bedea

How to cite

SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900 — Europe PMC (en), https://europepmc.org/article/MED/42151900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57c7c47bedea (Metraipolis archive dc_57c7c47bedea, sha256 19ad3be6112fc1904f1d6cbec8ccbec403946185747fe4579b1e26977d84a28e)
BibTeX
@misc{dc57c7c47bedea,
  title = {SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity — Europe PMC PMID:42151900},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42151900},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57c7c47bedea; sha256 19ad3be6112fc1904f1d6cbec8ccbec403946185747fe4579b1e26977d84a28e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151900. Agents can read the archived copy with the MCP tool read_document.